# Arrowhead Research Corporation (ARWR) Arrowhead Pharmaceuticals (ARWR) stock is surging, hitting a 52-week high driven by positive FDA designations and a Novartis collaboration. Increased social media buzz and analyst price target hikes are fueling this upward momentum. ### About Arrowhead Research Corporation Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing gene-silencing medicines for intractable diseases. Arrowhead Research Corporation uses the ticker $ARWR for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors. ### Insights - Arrowhead Research Corporation (ARWR) social dominance hit [------] which is 103% higher than it's daily average. - Arrowhead Research Corporation (ARWR) social dominance is up 210.22% from the previous [--] months. ### Price: $63.80  [Price 24-Hour Time-Series Raw Data](/topic/$arwr/time-series/close.tsv) The stock price is strongly positive, reaching a 52-week high, supported by recent positive news like FDA Breakthrough Therapy Designation and a Novartis collaboration. Increased social media mentions and trading volume, along with a raised price target from Piper Sandler, are amplifying this upward momentum. 24-Hour: 1.81% 7-Day: -1.12% 30-Day: -0.03% 1-Year High: $73 on 2026-02-02 1-Year Low: $10 on 2025-04-08 ### AltRank: [---]  [AltRank 24-Hour Time-Series Raw Data](/topic/$arwr/time-series/alt_rank.tsv) Arrowhead Research Corporation (ARWR) is currently AltRank #797 based on combined combined social and market metrics Daily Average: [---] [--] Week: [---] +277 [--] Month: [---] +117 [--] Months: [---] +298 [--] Year: [---] +253 1-Year High: [-----] on 2025-06-01 1-Year Low: [--] on 2025-03-15 ### Galaxy Score: [--]  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$arwr/time-series/galaxy_score.tsv) Current Value: [--] Daily Average: [--] [--] Week: [--] [---] [--] Month: [--] [---] [--] Months: [--] [---] [--] Year: [--] [---] 1-Year High: [--] on 2025-09-02 1-Year Low: [--] on 2025-09-16 ### Engagements: [-----] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$arwr/time-series/interactions.tsv) Current Value: [-----] Daily Average: [------] [--] Week: [------] -70% [--] Month: [-------] -63% [--] Months: [---------] +103% [--] Year: [---------] +64% 1-Year High: [-------] on 2026-01-06 1-Year Low: [-----] on 2026-02-15 Engagements by network (24h): YouTube: [--] Reddit: [--] X: [-----] TikTok: [--] ### Mentions: [---] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$arwr/time-series/posts_active.tsv) Current Value: [---] Daily Average: [---] [--] Week: [---] -31% [--] Month: [-----] -19% [--] Months: [-----] +88% [--] Year: [-----] +81% 1-Year High: [---] on 2025-11-28 1-Year Low: [--] on 2025-06-14 Mentions by network (24h): YouTube: [--] Reddit: [--] X: [---] TikTok: [--] ### Creators: [--] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$arwr/time-series/contributors_active.tsv) [--] unique social accounts have posts mentioning Arrowhead Research Corporation (ARWR) in the last [--] hours which is up 9.20% from [--] in the previous [--] hours Daily Average: [--] [--] Week: [---] -28% [--] Month: [---] -19% [--] Months: [-----] +25% [--] Year: [-----] +63% 1-Year High: [---] on 2025-06-28 1-Year Low: [--] on 2025-04-28 The most influential creators that mention Arrowhead Research Corporation in the last [--] hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@RNAiAnalyst](/creator/twitter/RNAiAnalyst) | [--] | [------] | [--] | [---] | | [@Tickeron](/creator/twitter/Tickeron) | [--] | [------] | [--] | [---] | | [@jonesallen99138](/creator/twitter/jonesallen99138) | [--] | [--] | [--] | [---] | | [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | [--] | [-----] | [--] | [--] | | [@BikeRieder](/creator/twitter/BikeRieder) | [--] | [-----] | [--] | [--] | | [@Hall8Jack](/creator/twitter/Hall8Jack) | [--] | [-----] | [--] | [--] | | [@BuyTheUgly](/creator/twitter/BuyTheUgly) | [--] | [--] | [--] | [--] | | [@BehaviorFin](/creator/twitter/BehaviorFin) | [--] | [-----] | [--] | [--] | | [@Oligo_bio](/creator/twitter/Oligo_bio) | [--] | [---] | [--] | [--] | | [@HedgeFundTips](/creator/twitter/HedgeFundTips) | [--] | [------] | [--] | [--] | [View More](/list/creators/$arwr/100) ### Sentiment: 74%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$arwr/time-series/sentiment.tsv) Current Value: 74% Daily Average: 76% [--] Week: 100% no change [--] Month: 91% +20% [--] Months: 91% +1% [--] Year: 91% +23% 1-Year High: 100% on 2025-06-12 1-Year Low: 24% on 2025-03-20 Most Supportive Themes: - RNAi Technology Focus: (20%) Community discussions on the strengths and potential of RNAi therapies, comparing them to other gene-editing technologies. - Pipeline Progress & Data: (15%) Discussions highlighting promising pipeline progress and potential data releases for programs like ARO-C3 and ARO-MMP7. - Novartis Deal: (10%) Arrowhead Pharmaceuticals' global license and collaboration agreement with Novartis for the ARO-SNCA program. Most Critical Themes: - Competitive Landscape: (10%) Frequent mentions of the competitive RNAi and broader biotech space, with comparisons to other companies. - Valuation Concerns: (5%) Some community members question Arrowhead's current valuation compared to companies with commercialized drugs. ### Social Dominance: 0.00737%  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$arwr/time-series/social_dominance.tsv) Current Value: 0.00737% Daily Average: 0.021% [--] Week: 0.023% +0.011% [--] Month: 0.043% +0.022% [--] Months: 0.043% +0.021% [--] Year: 0.043% +0.0051% 1-Year High: 0.087% on 2025-11-28 1-Year Low: 0.0055% on 2025-06-14 ### Market Dominance: 0.01%  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$arwr/time-series/market_dominance.tsv) Current Value: 0.01% Daily Average: 0% 1-Year High: 0.012% on 2026-02-02 1-Year Low: 0.00206% on 2025-04-08 ### Market Cap: $8,936,854,366  [Market Cap 24-Hour Time-Series Raw Data](/topic/$arwr/time-series/market_cap.tsv) Current Value: $8,936,854,366 Daily Average: $4,351,469,854 [--] Week: $8,893,444,387 -2.20% [--] Month: $8,936,854,366 -3.20% [--] Months: $8,936,854,366 +225% [--] Year: $8,936,854,366 +261% 1-Year High: $10,222,349,870 on 2026-02-02 1-Year Low: $1,240,760,298 on 2025-04-08 ### Top Arrowhead Research Corporation Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "$ARWR- another I sold too soon but glad for longs. Set price alerts to revisit if comes down to my range Redemplo off to a good start progress for core cardiovascular pipeline intriguing (if unclear) early data for obesity & nice optionality in neurdegen + other tissue types $ARWR (NP) From today's trades https://t.co/cnLchnECL3 $ARWR (NP) From today's trades https://t.co/cnLchnECL3" [X Link](https://x.com/jfais20/status/2022074770154746322) [@jfais20](/creator/x/jfais20) 2026-02-12T22:26Z 11.5K followers, [----] engagements "$beam $arwr the desire to rule out future liver issues could be a motivation to adopt genome editing along with the apparent lung benefit (but deep Z--M conversion needed); for #RNAi knockdown treatment only makes sense if liver disease has become apparent or somebody is at very high risk. $prme https://twitter.com/i/web/status/2022046440126615665 https://twitter.com/i/web/status/2022046440126615665" [X Link](https://x.com/RNAiAnalyst/status/2022046440126615665) [@RNAiAnalyst](/creator/x/RNAiAnalyst) 2026-02-12T20:33Z 21.2K followers, [----] engagements "$alny has initiated a phase [--] of fast-follower () ALN-2232 targeting Alk-7 in fat tissue for obesity and weight mgmt as quarterly product revs reach $1B: $arwr $wve https://finance.yahoo.com/news/alnylam-pharmaceuticals-reports-fourth-quarter-130000068.html https://finance.yahoo.com/news/alnylam-pharmaceuticals-reports-fourth-quarter-130000068.html" [X Link](https://x.com/RNAiAnalyst/status/2021936314401042753) [@RNAiAnalyst](/creator/x/RNAiAnalyst) 2026-02-12T13:15Z 21.2K followers, [----] engagements "#earnings after the close on Thursday February [--] [----] $AMZN $IREN $RDDT $MSTR $RBLX $BE $CLSK $AFRM $FTNT $DOCS $TEAM $MCHP $GOLD $DLR $ARW $ARWR $MPWR $BILL $BBD $G $RGA $VSAT $ILMN $MOH $GEN $HUBG $FLS $KN $BYD $CNO $COTY $BARK $MITK $MTD $NVST $PI $VTR $STEP $ATR $ASYS $COUR $CDP $LION $CUZ $EHC $EQR $STRT $SYNA $SSNC $RBBN https://www.earningswhispers.com/calendar https://www.earningswhispers.com/calendar" [X Link](https://x.com/eWhispers/status/2019449937860215005) [@eWhispers](/creator/x/eWhispers) 2026-02-05T16:35Z 551.6K followers, 67K engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
Arrowhead Pharmaceuticals (ARWR) stock is surging, hitting a 52-week high driven by positive FDA designations and a Novartis collaboration. Increased social media buzz and analyst price target hikes are fueling this upward momentum.
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing gene-silencing medicines for intractable diseases.
Arrowhead Research Corporation uses the ticker $ARWR for trading. Listed in the Stocks category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
The stock price is strongly positive, reaching a 52-week high, supported by recent positive news like FDA Breakthrough Therapy Designation and a Novartis collaboration. Increased social media mentions and trading volume, along with a raised price target from Piper Sandler, are amplifying this upward momentum.
24-Hour: 1.81% 7-Day: -1.12% 30-Day: -0.03%
1-Year High: $73 on 2026-02-02
1-Year Low: $10 on 2025-04-08
AltRank 24-Hour Time-Series Raw Data
Arrowhead Research Corporation (ARWR) is currently AltRank #797 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] +277
[--] Month: [---] +117
[--] Months: [---] +298
[--] Year: [---] +253
1-Year High: [-----] on 2025-06-01
1-Year Low: [--] on 2025-03-15
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-09-02
1-Year Low: [--] on 2025-09-16
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [------] -70%
[--] Month: [-------] -63%
[--] Months: [---------] +103%
[--] Year: [---------] +64%
1-Year High: [-------] on 2026-01-06
1-Year Low: [-----] on 2026-02-15
Engagements by network (24h): YouTube: [--] Reddit: [--] X: [-----] TikTok: [--]
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] -31%
[--] Month: [-----] -19%
[--] Months: [-----] +88%
[--] Year: [-----] +81%
1-Year High: [---] on 2025-11-28
1-Year Low: [--] on 2025-06-14
Mentions by network (24h): YouTube: [--] Reddit: [--] X: [---] TikTok: [--]
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Arrowhead Research Corporation (ARWR) in the last [--] hours which is up 9.20% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] -28%
[--] Month: [---] -19%
[--] Months: [-----] +25%
[--] Year: [-----] +63%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-04-28
The most influential creators that mention Arrowhead Research Corporation in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @RNAiAnalyst | [--] | [------] | [--] | [---] |
| @Tickeron | [--] | [------] | [--] | [---] |
| @jonesallen99138 | [--] | [--] | [--] | [---] |
| @NightOwlBiotech | [--] | [-----] | [--] | [--] |
| @BikeRieder | [--] | [-----] | [--] | [--] |
| @Hall8Jack | [--] | [-----] | [--] | [--] |
| @BuyTheUgly | [--] | [--] | [--] | [--] |
| @BehaviorFin | [--] | [-----] | [--] | [--] |
| @Oligo_bio | [--] | [---] | [--] | [--] |
| @HedgeFundTips | [--] | [------] | [--] | [--] |
Sentiment 24-Hour Time-Series Raw Data
Current Value: 74%
Daily Average: 76%
[--] Week: 100% no change
[--] Month: 91% +20%
[--] Months: 91% +1%
[--] Year: 91% +23%
1-Year High: 100% on 2025-06-12
1-Year Low: 24% on 2025-03-20
Most Supportive Themes:
Most Critical Themes:
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00737%
Daily Average: 0.021%
[--] Week: 0.023% +0.011%
[--] Month: 0.043% +0.022%
[--] Months: 0.043% +0.021%
[--] Year: 0.043% +0.0051%
1-Year High: 0.087% on 2025-11-28
1-Year Low: 0.0055% on 2025-06-14
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.01%
Daily Average: 0%
1-Year High: 0.012% on 2026-02-02
1-Year Low: 0.00206% on 2025-04-08
Market Cap 24-Hour Time-Series Raw Data
Current Value: $8,936,854,366
Daily Average: $4,351,469,854
[--] Week: $8,893,444,387 -2.20%
[--] Month: $8,936,854,366 -3.20%
[--] Months: $8,936,854,366 +225%
[--] Year: $8,936,854,366 +261%
1-Year High: $10,222,349,870 on 2026-02-02
1-Year Low: $1,240,760,298 on 2025-04-08
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"$ARWR- another I sold too soon but glad for longs. Set price alerts to revisit if comes down to my range Redemplo off to a good start progress for core cardiovascular pipeline intriguing (if unclear) early data for obesity & nice optionality in neurdegen + other tissue types $ARWR (NP) From today's trades https://t.co/cnLchnECL3 $ARWR (NP) From today's trades https://t.co/cnLchnECL3"
X Link @jfais20 2026-02-12T22:26Z 11.5K followers, [----] engagements
"$beam $arwr the desire to rule out future liver issues could be a motivation to adopt genome editing along with the apparent lung benefit (but deep Z--M conversion needed); for #RNAi knockdown treatment only makes sense if liver disease has become apparent or somebody is at very high risk. $prme https://twitter.com/i/web/status/2022046440126615665 https://twitter.com/i/web/status/2022046440126615665"
X Link @RNAiAnalyst 2026-02-12T20:33Z 21.2K followers, [----] engagements
"$alny has initiated a phase [--] of fast-follower () ALN-2232 targeting Alk-7 in fat tissue for obesity and weight mgmt as quarterly product revs reach $1B: $arwr $wve https://finance.yahoo.com/news/alnylam-pharmaceuticals-reports-fourth-quarter-130000068.html https://finance.yahoo.com/news/alnylam-pharmaceuticals-reports-fourth-quarter-130000068.html"
X Link @RNAiAnalyst 2026-02-12T13:15Z 21.2K followers, [----] engagements
"#earnings after the close on Thursday February [--] [----] $AMZN $IREN $RDDT $MSTR $RBLX $BE $CLSK $AFRM $FTNT $DOCS $TEAM $MCHP $GOLD $DLR $ARW $ARWR $MPWR $BILL $BBD $G $RGA $VSAT $ILMN $MOH $GEN $HUBG $FLS $KN $BYD $CNO $COTY $BARK $MITK $MTD $NVST $PI $VTR $STEP $ATR $ASYS $COUR $CDP $LION $CUZ $EHC $EQR $STRT $SYNA $SSNC $RBBN https://www.earningswhispers.com/calendar https://www.earningswhispers.com/calendar"
X Link @eWhispers 2026-02-05T16:35Z 551.6K followers, 67K engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$arwr